Mariano
Ponz Sarvisé
Consultor Médico
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (6)
2022
-
Identifying FGFR2 fusions/rearrangements in cholangiocarcinoma patients using a novel cfDNA algorithm for treatment with RLY-4008, a highly selective irreversible FGFR2 inhibitor
European Journal of Cancer, Vol. 174, pp. S116
2019
-
Identification of resistance pathways specific to malignancy using organoid models of pancreatic cancer
Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6742-6755
-
Use of machine-learning algorithms in intensified preoperative therapy of pancreatic cancer to predict individual risk of relapse
Cancers, Vol. 11, Núm. 5
2016
-
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Cell, Vol. 166, Núm. 4, pp. 963-976
2015
-
Mouse Models of Pancreatic Ductal Adenocarcinoma
Hematology/Oncology Clinics of North America, Vol. 29, Núm. 4, pp. 609-617
-
Organoid models of human and mouse ductal pancreatic cancer
Cell, Vol. 160, Núm. 1-2, pp. 324-338